The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study
Abstract
Background— Small myocardial infarctions after percutaneous coronary intervention have been associated with higher risk of cardiac events during follow-up. Observational studies have suggested that statins may lower the risk of procedural myocardial injury. The aim of our study was to confirm this hypothesis in a randomized study. Methods and Results— One hundred fifty-three patients with chronic stable angina without previous statin treatment were enrolled in the study. Patients scheduled for elective coronary intervention were randomized to atorvastatin (40 mg/d, n=76) or placebo (n=77) 7 days before the procedure. Creatine kinase-MB, troponin I, and myoglobin levels were measured at baseline and at 8 and 24 hours after the procedure. Detection of markers of myocardial injury above the upper normal limit was significantly lower in the statin group versus the placebo group: 12% versus 35% for creatine kinase-MB ( P =0.001), 20% versus 48% for troponin I ( P =0.0004), and 22% versus 51% for myoglobin ( P =0.0005). Myocardial infarction by creatine kinase-MB determination was detected after coronary intervention in 5% of patients in the statin group and in 18% of those in the placebo group ( P =0.025). Postprocedural peak levels of creatine kinase-MB (2.9±3 versus 7.5±18 ng/mL, P =0.007), troponin I (0.09±0.2 versus 0.47±1.3 ng/mL, P =0.0008), and myoglobin (58±36 versus 81±49 ng/mL, P =0.0002) were also significantly lower in the statin than in the placebo group. Conclusions— Pretreatment with atorvastatin 40 mg/d for 7 days significantly reduces procedural myocardial injury in elective coronary intervention. These results may influence practice patterns with regard to adjuvant pharmacological therapy before percutaneous revascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Antman, E., Bassand, J.-P., Klein, W., Ohman, M., Lopez Sendon, J. L., Rydén, L., Simoons, M., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,821
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Epistent Investigators, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)06113-3 · Cited by 1,346
Topol, E. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85010-1 · Cited by 1,095
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Self-citationSerruys, P. W. J. C. (2002) · JAMA · doi:10.1001/jama.287.24.3215 · Cited by 719
Notarbartolo, A., Davı̀, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. P. L., & Patrono, C. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.247 · Cited by 259
Ioannidis, J. P. A., Karvouni, E., & Katritsis, D. G. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)01044-1 · Cited by 254
Chan, A. W., Bhatt, D. L., Chew, D. P., Quinn, M. J., Moliterno, D. J., Topol, E. J., & Ellis, S. G. (2002) · Circulation · doi:10.1161/hc0602.103586 · Cited by 248
Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation
Walter, D. H., Fichtlscherer, S., Sellwig, M., Auch-Schwelk, W., Schächinger, V., & Zeiher, A. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01193-1 · Cited by 222
Ellis, S. G., Chew, D., Chan, A., Whitlow, P. L., Schneider, J. P., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000028146.71416.2e · Cited by 209
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions
Chan, A. W., Bhatt, D. L., Chew, D. P., Reginelli, J., Schneider, J. P., Topol, E. J., & Ellis, S. G. (2003) · Circulation · doi:10.1161/01.cir.0000060541.18923.e9 · Cited by 207
Wassmann, S., Faul, A., Hennen, B., Scheller, B., Böhm, M., & Nickenig, G. (2003) · Circulation Research · doi:10.1161/01.res.0000099503.13312.7b · Cited by 177
Herrmann, J., Lerman, A., Baumgart, D., Volbracht, L., Schulz, R., von Birgelen, C., Haude, M., Heusch, G., & Erbel, R. (2002) · Circulation · doi:10.1161/01.cir.0000037520.89770.5e · Cited by 161
Troponin I elevation and cardiac events after percutaneous coronary intervention
Ricciardi, M. J., Davidson, C. J., Gubernikoff, G., Beohar, N., Eckman, L. J., Parker, M. A., & Bonow, R. O. (2003) · American Heart Journal · doi:10.1067/mhj.2003.2 · Cited by 139
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions
Fuchs, S., Kornowski, R., Mehran, R., Lansky, A. J., Satler, L. F., Pichard, A. D., Kent, K. M., Clark, C. E., Stone, G. W., & Leon, M. B. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00699-8 · Cited by 133
Multicenter Evaluation of an Automated Assay for Troponin I
Uettwiller-Geiger, D. L., Wu, A. H. B., Apple, F. S., Jevans, A. W., Venge, P., Olson, M. D., Darte, C., Woodrum, D. L., Roberts, S., & Chan, S. Y. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.6.869 · Cited by 104
Frequency and prognostic value of cardiac troponin I elevation after coronary stenting
Garbarz, É., Iung, B., Lefèvre, G., Makita, Y., Farah, B., Michaud, P., Graïne, H., & Vahanian, A. S. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00369-0 · Cited by 80
Harris, B. M., Nageh, T., Jt, M., Thomas, M. R., & Sherwood, R. A. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001900075 · Cited by 59
Correia, L. C. L., Sposito, A. C., Lima, J. C., de Magalhães, L. P., Passos, L. C. S., Rocha, M. D. S., D’Oliveira, A., & Esteves, J. P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00630-1 · Cited by 54
Jones, S. P., & Lefer, D. J. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00899.x · Cited by 42
Kurz, D. J., Naegeli, B., & Bertel, O. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90306-5 · Cited by 38
Cited by
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl001 · Cited by 1,336
Troponin: the biomarker of choice for the detection of cardiac injury
Babuin, L., & Jaffe, A. S. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050141 · Cited by 686
Metadata
- Authors
- Pasceri, V., Patti, G., Nusca, A., Pristipino, C., Richichi, G., & Di Sciascio, G.
- Venue
- Circulation
- Published
- 2004-08-10
- Volume
- 110
- Issue
- 6
- Pages
- 674-678
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2098885552
- Cited by
- 466
- References
- 26
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.